Novo Nordisk CEO: Oral Semaglutide Launch In 2020, Novel Obesity Drugs Sought

 
• By Sten Stovall
  
NovoNordisk
Novo Nordisk reported strong 1Q sales, with newly launched products Ozempic and Saxenda leading the way • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business